Omega-3s: The Brain-Boosting Fat You Need for Mental Health and Beyond

Written By Dr. Sarah McLaughlin

Omega-3 Essential Fatty Acids (EFAs) have been shown through research to play a crucial role in mental health. The two primary types of omega-3 fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These fatty acids are not only vital for mental health but also for physical health. Research indicates that omega-3s help reduce inflammation in the body, which is linked to various chronic conditions. Additionally, they can lower high blood pressure and reduce triglyceride levels. Since the brain is nearly 60% fat, it is essential to support brain health by consuming essential fatty acids through diet and, when necessary, supplementation.

EPA and DHA, in particular, support cognitive function and are critical during pregnancy and early childhood for brain development. Their anti-inflammatory effects on the brain contribute significantly to reducing symptoms of mental health disorders.

A 2006 study by Hoen and colleagues examined red blood cell (RBC) polyunsaturated fatty acids (PUFAs) and their association with schizophrenia. The study concluded that lower RBC PUFA levels were significantly associated with schizophrenia, suggesting that PUFAs may play a role in the development and treatment of the condition.

In 2023, Kelaiditis and his team conducted a systematic review and meta-analysis on the effects of long-chain omega-3 PUFAs on reducing anxiety and depression in adults. The findings revealed that omega-3 supplementation could benefit mental health by alleviating symptoms of anxiety and depression. However, the results varied depending on dosage and individual factors. A follow-up study in 2024 reinforced these findings, highlighting the positive effects of omega-3 supplementation in treating mood disorders. The research showed that omega-3 supplementation is generally well-tolerated and effective in managing anxiety and depression.

Omega-3s have also been found to improve symptoms in individuals with major depressive disorder, bipolar disorder, and attention and focus difficulties. EPA, in particular, has shown more benefit than DHA in treating these conditions. For depression treatment, the American Psychiatric Association recommends EPA-enriched formulations, where EPA constitutes at least 60% of the total EPA + DHA content. The effective dose range for EPA is typically between 1 g/day and 2 g/day. Meta-analyses support that these doses can significantly reduce the severity of depression.

In conclusion, omega-3 fatty acids, particularly EPA and DHA, are essential nutrients offering wide-ranging benefits for mental and physical health. From reducing inflammation and supporting heart health to improving cognitive function and alleviating symptoms of mood disorders like anxiety and depression, omega-3s play a critical role in overall well-being. Their impact on brain development during pregnancy and early childhood further underscores the importance of these fatty acids for long-term health. With growing evidence supporting their efficacy, omega-3 supplementation stands out as a promising and well-tolerated option for managing mental health conditions. Incorporating omega-3-rich foods or supplements into your diet can be a simple yet powerful step toward optimizing your health, enhancing your mood, and supporting brain function.




References: 
•  Hoen, W. P., Lijmer, J. G., Duran, M., Wanders, R. J., van Beveren, N. J., & de Haan, L. (2006). Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis. Journal of Clinical Psychiatry, 67(12), 1954-1967. https://doi.org/10.4088/JCP.v67n1217
•  Kelaiditis, C. F., Gibson, E. L., & Dyall, S. C. (2023). Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults: A systematic review and meta-analysis of randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 92, 102572. https://doi.org/10.1016/j.plefa.2023.102572
•  Kelaiditis, C. F., Gibson, E. L., & Dyall, S. C. (2024). Efficacy and safety of omega-3 fatty acids supplementation for anxiety and depression: A systematic review and meta-analysis of randomized controlled trials. BMC Psychiatry, 24, 1-15. https://doi.org/10.1186/s12888-024-05881-2
•  The Integrative Psychiatry Institute. (n.d.). Micronutrient lecture series. Retrieved February 23, 2025, from https://integrativepsychiatry.net/micronutrient-lecture-series/
Dr. Sarah McLaughlin

Dr. McLaughlin is a board-certified psychiatrist with extensive training and experience in the field. She earned her medical degree from the Philadelphia College of Osteopathic Medicine, followed by a four-year residency at Geisinger Medical Center in Pennsylvania. In addition to her clinical work, she served as an assistant professor at the Geisinger Commonwealth School of Medicine.

Now residing in Georgia with her husband and four children, Dr. McLaughlin is dedicated to her Christian faith. She is currently pursuing her Master of Divinity at Liberty University. With a strong focus on mental health, she embraces a holistic approach that aims to identify and address the underlying causes of psychiatric conditions, rather than simply managing symptoms. Dr. McLaughlin has also advanced her education through the Institute of Functional Medicine, further enhancing her ability to provide comprehensive care.

Next

The Fiber Connection: How What You Eat Impacts Depression and Anxiety